loading
Rhythm Pharmaceuticals Inc stock is traded at $100.82, with a volume of 492.57K. It is up +0.61% in the last 24 hours and up +0.55% over the past month. Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
See More
Previous Close:
$100.21
Open:
$99.78
24h Volume:
492.57K
Relative Volume:
0.78
Market Cap:
$6.70B
Revenue:
$136.86M
Net Income/Loss:
$-168.69M
P/E Ratio:
-35.88
EPS:
-2.81
Net Cash Flow:
$-113.49M
1W Performance:
+1.82%
1M Performance:
+0.55%
6M Performance:
+74.34%
1Y Performance:
+110.17%
1-Day Range:
Value
$97.97
$102.92
1-Week Range:
Value
$96.30
$102.92
52-Week Range:
Value
$45.91
$106.52

Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile

Name
Name
Rhythm Pharmaceuticals Inc
Name
Phone
857-264-4280
Name
Address
222 BERKELEY STREET, BOSTON, MA
Name
Employee
283
Name
Twitter
@rhythmpharma
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
RYTM's Discussions on Twitter

Compare RYTM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RYTM
Rhythm Pharmaceuticals Inc
100.82 6.66B 136.86M -168.69M -113.49M -2.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-10-25 Initiated Goldman Buy
Jul-07-25 Initiated Leerink Partners Outperform
Apr-07-25 Upgrade BofA Securities Neutral → Buy
Mar-05-25 Resumed Stifel Buy
Jan-02-25 Initiated Jefferies Buy
Dec-20-24 Initiated Oppenheimer Outperform
Oct-21-24 Initiated Guggenheim Buy
Sep-18-24 Initiated H.C. Wainwright Buy
Sep-17-24 Initiated JMP Securities Mkt Outperform
May-08-24 Downgrade BofA Securities Buy → Neutral
Dec-19-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-01-23 Upgrade BofA Securities Neutral → Buy
Jan-18-23 Resumed Canaccord Genuity Buy
Aug-08-22 Upgrade Goldman Neutral → Buy
Aug-05-22 Upgrade BofA Securities Underperform → Neutral
Jun-17-22 Reiterated Needham Buy
Mar-02-22 Resumed Stifel Buy
Feb-17-22 Upgrade Ladenburg Thalmann Neutral → Buy
Dec-08-21 Initiated Wells Fargo Overweight
Nov-19-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-14-21 Resumed Goldman Neutral
Aug-04-21 Downgrade BofA Securities Neutral → Underperform
Aug-04-21 Downgrade Ladenburg Thalmann Buy → Neutral
Nov-30-20 Downgrade BofA Securities Buy → Neutral
Jan-08-20 Initiated Goldman Sell
Jul-12-19 Upgrade Stifel Hold → Buy
Jul-08-19 Initiated Canaccord Genuity Buy
Mar-13-19 Initiated Ladenburg Thalmann Buy
Sep-07-18 Resumed Morgan Stanley Overweight
Jun-25-18 Reiterated Needham Buy
Jun-15-18 Reiterated Needham Buy
Oct-30-17 Initiated BofA/Merrill Buy
Oct-30-17 Initiated Needham Buy
View All

Rhythm Pharmaceuticals Inc Stock (RYTM) Latest News

pulisher
Oct 12, 2025

Long term hold vs stop loss in Rhythm Pharmaceuticals Inc.July 2025 Big Picture & Safe Entry Momentum Tips - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

What analysts say about Rhythm Pharmaceuticals Inc 1RV stockVolatility Index Analysis & Minimize Portfolio Damage with Warnings - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Using RSI to spot recovery in Rhythm Pharmaceuticals Inc.2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Should you hold or exit Rhythm Pharmaceuticals Inc. now2025 Top Gainers & Trade Opportunity Analysis - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What indicators show strength in Rhythm Pharmaceuticals Inc.Weekly Profit Recap & Capital Efficiency Focused Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Leo Wealth LLC Has $850,000 Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock a safe buy pre earningsCEO Change & Consistent Growth Equity Picks - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Rhythm Pharma Stock Gears Up For Its Next Move - inkl

Oct 09, 2025
pulisher
Oct 09, 2025

How to recover losses in Rhythm Pharmaceuticals Inc. stock2025 Market Outlook & Fast Exit and Entry Strategy Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Rhythm Pharmaceuticals (NASDAQ:RYTM) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Is Rhythm Pharmaceuticals Inc. meeting your algorithmic filter criteria2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Why Rhythm Pharmaceuticals Inc. (1RV) stock could be next leaderWeekly Loss Report & Free Weekly Chart Analysis and Trade Guides - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

Is Rhythm Pharmaceuticals Inc a good long term investmentEconomic Indicators Overview & Low Risk Capital Growth Plans - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowIndex Update & Low Volatility Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What momentum shifts mean for Rhythm Pharmaceuticals Inc.July 2025 Reactions & Weekly Hot Stock Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Will Rhythm Pharmaceuticals Inc. rebound enough to break evenRecession Risk & Verified High Yield Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Using data tools to time your Rhythm Pharmaceuticals Inc. exitJuly 2025 Macro Moves & Intraday High Probability Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Rhythm Pharmaceuticals Inc. stock cheap at current valuationWeekly Trading Summary & Weekly Stock Breakout Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Institutional scanner results for Rhythm Pharmaceuticals Inc.Market Volume Report & Fast Exit/Entry Strategy Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is Rhythm Pharmaceuticals Inc. stock dividend yield sustainableMarket Performance Recap & Fast Gaining Stock Strategy Reports - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead? - Yahoo Finance

Oct 03, 2025
pulisher
Oct 02, 2025

Is Rhythm Pharmaceuticals Inc. (1RV) stock a buy before earnings resultsJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com

Oct 02, 2025
pulisher
Sep 30, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com

Sep 30, 2025
pulisher
Sep 30, 2025

Bardet-Biedl Syndrome Pipeline 2025: Pioneering Clinical Developments by 8+ Global Leaders – DelveInsight | Featuring Rhythm Pharmaceuticals - Barchart.com

Sep 30, 2025
pulisher
Sep 29, 2025

Rhythm Pharmaceuticals stock price target raised by H.C. Wainwright to $110 - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

HC Wainwright & Co. Maintains Rhythm Pharmaceuticals (RYTM) Buy Recommendation - Nasdaq

Sep 29, 2025
pulisher
Sep 29, 2025

RYTM: HC Wainwright Raises Price Target, Maintains Buy Rating | - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring an 18.64% Potential Upside in the Rare Disease Biotech Space - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 29, 2025

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A Biotech Play with 18.64% Upside Potential - DirectorsTalk Interviews

Sep 29, 2025
pulisher
Sep 28, 2025

Chart based exit strategy for Rhythm Pharmaceuticals Inc.Weekly Investment Recap & Technical Pattern Based Signals - newser.com

Sep 28, 2025

Rhythm Pharmaceuticals Inc Stock (RYTM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Rhythm Pharmaceuticals Inc Stock (RYTM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Shulman Joseph
Chief Technical Officer
Sep 02 '25
Sale
105.30
16,781
1,767,006
8,509
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Cap:     |  Volume (24h):